Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
Asmane I, Kurtz JE, Bajard A, Guastalla JP, Meeus P, Tredan O, Labidi Galy I, Moullet I, Ardisson P, Vincent L, Coeffic D, Dufresne A, Bergerat JP, Ray-Coquard I.
Asmane I, et al. Among authors: bergerat jp.
Bull Cancer. 2011 Oct;98(9):80-9. doi: 10.1684/bdc.2011.1436.
Bull Cancer. 2011.
PMID: 21926034
Free article.